Takahashi T - Search Results

1

Individual-level data on the relationships of progression-free survival, post-progression survival, and tumor response with overall survival in patients with advanced non-squamous non-small cell lung cancer.

Imai H, Takahashi T, Mori K, Ono A, Akamatsu H, Shukuya T, Taira T, Kenmotsu H, Naito T, Murakami H, Endo M, Nakajima T, Yamamoto N. Imai H, et al. Among authors: takahashi t. Neoplasma. 2014;61(2):233-40. doi: 10.4149/neo_2014_030. Neoplasma. 2014. PMID: 24299320

2

Phase II trial of S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.

Ohyanagi F, Yamamoto N, Horiike A, Harada H, Kozuka T, Murakami H, Gomi K, Takahashi T, Morota M, Nishimura T, Endo M, Nakamura Y, Tsuya A, Horai T, Nishio M. Ohyanagi F, et al. Among authors: takahashi t. Br J Cancer. 2009 Jul 21;101(2):225-31. doi: 10.1038/sj.bjc.6605152. Br J Cancer. 2009. PMID: 19603031 Free PMC article. Clinical Trial.

3

¹⁸F-FDG uptake on PET could be a predictive marker of excision repair cross-complementation group 1 (ERCC1) expression in patients with thoracic neoplasms?

Kaira K, Endo M, Shukuya T, Kenmotsu H, Naito T, Ono A, Tsuya A, Nakamua Y, Takahashi T, Murakami H, Kondo H, Nakajima T, Yamamoto N. Kaira K, et al. Among authors: takahashi t. Neoplasma. 2012;59(3):257-63. doi: 10.4149/neo_2012_033. Neoplasma. 2012. PMID: 22329847

4

Phase II clinical trial of S-1 plus oral leucovorin in previously treated patients with non-small-cell lung cancer.

Naito T, Seto T, Takeda K, Goto K, Okamoto I, Nakagawa K, Ohba T, Murakami H, Takahashi T, Yamanaka T, Yamamoto N. Naito T, et al. Among authors: takahashi t. Lung Cancer. 2014 Dec;86(3):339-43. doi: 10.1016/j.lungcan.2014.10.010. Epub 2014 Oct 23. Lung Cancer. 2014. PMID: 25453619 Clinical Trial.

5

Phase I study of continuous afatinib (BIBW 2992) in patients with advanced non-small cell lung cancer after prior chemotherapy/erlotinib/gefitinib (LUX-Lung 4).

Murakami H, Tamura T, Takahashi T, Nokihara H, Naito T, Nakamura Y, Nishio K, Seki Y, Sarashina A, Shahidi M, Yamamoto N. Murakami H, et al. Among authors: takahashi t. Cancer Chemother Pharmacol. 2012 Apr;69(4):891-9. doi: 10.1007/s00280-011-1738-1. Epub 2011 Nov 10. Cancer Chemother Pharmacol. 2012. PMID: 22071596 Clinical Trial.

6

Phase 1 study of lenvatinib combined with carboplatin and paclitaxel in patients with non-small-cell lung cancer.

Nishio M, Horai T, Horiike A, Nokihara H, Yamamoto N, Takahashi T, Murakami H, Yamamoto N, Koizumi F, Nishio K, Yusa W, Koyama N, Tamura T. Nishio M, et al. Among authors: takahashi t. Br J Cancer. 2013 Aug 6;109(3):538-44. doi: 10.1038/bjc.2013.374. Epub 2013 Jul 16. Br J Cancer. 2013. PMID: 23860537 Free PMC article. Clinical Trial.

7

Mutant allele frequency predicts the efficacy of EGFR-TKIs in lung adenocarcinoma harboring the L858R mutation.

Ono A, Kenmotsu H, Watanabe M, Serizawa M, Mori K, Imai H, Taira T, Naito T, Murakami H, Nakajima T, Ohde Y, Endo M, Yamamoto N, Koh Y, Takahashi T. Ono A, et al. Among authors: takahashi t. Ann Oncol. 2014 Oct;25(10):1948-1953. doi: 10.1093/annonc/mdu251. Epub 2014 Jul 9. Ann Oncol. 2014. PMID: 25009007 Free article.

8

CYP2C19 genotype-based phase I studies of a c-Met inhibitor tivantinib in combination with erlotinib, in advanced/metastatic non-small cell lung cancer.

Yamamoto N, Murakami H, Hayashi H, Fujisaka Y, Hirashima T, Takeda K, Satouchi M, Miyoshi K, Akinaga S, Takahashi T, Nakagawa K. Yamamoto N, et al. Among authors: takahashi t. Br J Cancer. 2013 Nov 26;109(11):2803-9. doi: 10.1038/bjc.2013.588. Epub 2013 Oct 29. Br J Cancer. 2013. PMID: 24169346 Free PMC article. Clinical Trial.

9

High incidence of interstitial lung disease following practical use of osimertinib in patients who had undergone immediate prior nivolumab therapy.

Kotake M, Murakami H, Kenmotsu H, Naito T, Takahashi T. Kotake M, et al. Among authors: takahashi t. Ann Oncol. 2017 Mar 1;28(3):669-670. doi: 10.1093/annonc/mdw647. Ann Oncol. 2017. PMID: 27993813 Free article. No abstract available.

10

[Chemotherapy with high-dose carboplatin for inoperable non-small cell lung cancer].

Daido K, Arita K, Ejima T, Hirata T, Takahashi T, Oguri T, Yamamoto N, Hasegawa K, Yamakido M. Daido K, et al. Among authors: takahashi t. Gan To Kagaku Ryoho. 1993 Oct;20(13):1983-8. Gan To Kagaku Ryoho. 1993. PMID: 8215472 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,939 results

Search Page

Filters